Power Law company profile

Iovance Biotherapeutics

Biotech & Life Sciences · New York City, United States · Founded 2007 · IPO 2010 Unicorn

T-cell-based immunotherapy products for the treatment of cancer

Valuation

$1.25B

Market cap · May/2026

Revenue

$264M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $10B+ revenueThoroughbred · Power Law outcome

Global footprint

Where Iovance Biotherapeutics has talent and traffic

AI talent share

0.1% of workforce is AI talent
(1 of 918 staff)

Core AI00%

Other AI10.11%

Non-AI workforce91799.89%

Workforce by country

7 countries with
team presence

🇺🇸 United States99.2%

🇬🇧 United Kingdom0.4%

🇮🇹 Italy0.1%

🇳🇱 Netherlands0.1%

🇨🇦 Canada0.1%

Top 5 of 7 shown

Web traffic by country

22K monthly visits
across markets

🇺🇸 United States42.3%

🇬🇧 United Kingdom9.1%

🇨🇦 Canada6.4%

🇩🇪 Germany5.9%

🇯🇵 Japan5.5%

Top 5 markets shown

Patent intelligence

$73M patent portfolio · 107 active families

Estimated portfolio value

$73M

5.9% of market cap · 4.3× smaller than top peer Exact Sciences ($319M)

107 active patent families

Where Iovance Biotherapeutics innovates OncologyCancer researchTumor-infiltrating lymphocytesLymphocyteCarcinosis

Where Iovance Biotherapeutics concentrates vs peers

Each axis is a top-10 topic across Iovance Biotherapeutics and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Iovance Biotherapeutics

An AI-synthesized read of the highest-engagement posts about Iovance Biotherapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Iovance Biotherapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles